142 related articles for article (PubMed ID: 6171686)
21. The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.
Marshall RJ; Parratt JR
Br J Pharmacol; 1977 Feb; 59(2):311-22. PubMed ID: 837018
[TBL] [Abstract][Full Text] [Related]
22. Dose related coronary and systemic haemodynamic effects of intravenous bepridil in patients with coronary artery disease.
Remme WJ; van Hoogenhuyze DC; Krauss XH; Hofman A; Storm CJ; Kruyssen HA
Eur Heart J; 1987 Feb; 8(2):130-40. PubMed ID: 3494607
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological effects of lidocaine, l-chlorpheniramine, and bepridil on rabbit sinus node pacemaker cells.
Kane KA; Berdeja García GY; Sánchez-Pérez S; Pastelín G
J Cardiovasc Pharmacol; 1983; 5(1):102-8. PubMed ID: 6186843
[TBL] [Abstract][Full Text] [Related]
24. Depression of automaticity of the rabbit SA node by bepridil and nifedipine.
Goto J; Sperelakis N
Eur J Pharmacol; 1984 Mar; 99(2-3):227-31. PubMed ID: 6610560
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological effects of lidocaine, l-chlorpheniramine, and bepridil on normal and ouabain-intoxicated canine Purkinje fibers.
Kane KA; Berdeja García GY; Sánchez-Pérez S; Pastelín G
J Cardiovasc Pharmacol; 1983; 5(1):109-15. PubMed ID: 6186844
[TBL] [Abstract][Full Text] [Related]
26. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of a new orally active antidysrhythmic agent, Organon 6001, on the cardiac action potential of human ventricular muscle and sheep Purkinje fibres [proceedings].
Kane KA
Br J Pharmacol; 1977 Nov; 61(3):457P-458P. PubMed ID: 588815
[No Abstract] [Full Text] [Related]
28. [Efficacy of oral bepridil in ventricular arrhythmias in stable coronary insufficiency].
Rio A; Pasco A; Dupont T; Deroubaix G; Moulinie E; Rossignol B; Pellet J; Brechenmacher C
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():75-8. PubMed ID: 3938263
[TBL] [Abstract][Full Text] [Related]
29. Effects of dantrolene sodium in rodent models of cardiac arrhythmia.
Brooks RR; Carpenter JF; Jones SM; Gregory CM
Eur J Pharmacol; 1989 May; 164(3):521-30. PubMed ID: 2767123
[TBL] [Abstract][Full Text] [Related]
30. Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia.
Millar JS; Vaughan Williams EM
Br J Pharmacol; 1982 Mar; 75(3):469-78. PubMed ID: 7066601
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
[TBL] [Abstract][Full Text] [Related]
32. Bepridil: a new long-acting calcium channel blocking agent.
Zeller FP; Spinler SA
Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.
Tamargo J; Delgado C
Eur J Pharmacol; 1985 Dec; 118(3):331-40. PubMed ID: 4085559
[TBL] [Abstract][Full Text] [Related]
34. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R
J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
Brown BS
J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of calcium antagonists.
Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
[TBL] [Abstract][Full Text] [Related]
37. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
Carmeliet E
Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
[TBL] [Abstract][Full Text] [Related]
38. Effect of bepridil on membrane currents of rabbit sinoatrial node cells.
Kotake H; Igawa O; Miyamoto J; Hasegawa J; Kosaka T; Furuse T; Mashiba H
Arzneimittelforschung; 1987 Apr; 37(4):424-7. PubMed ID: 3496889
[TBL] [Abstract][Full Text] [Related]
39. Antiarrhythmic and hemodynamic effects of prifuroline.
Benharkate M; Plassard G; Legeai J; Worcel M
Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
[TBL] [Abstract][Full Text] [Related]
40. Effects of bepridil on Ca2+ uptake by cardiac mitochondria.
Younes A; Schneider JM
Biochem Pharmacol; 1984 Apr; 33(8):1363-6. PubMed ID: 6231932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
